Urgent surgery for RD gives best post-op VA

Article

Urgent vitrectomy/phacovitrectomy to treat retinal detachment will produce the best postoperative visual acuity when it is conducted within 2 days or less of the detachment, according to a recent study.

Urgent vitrectomy/phacovitrectomy to treat retinal detachment will produce the best postoperative visual acuity when it is conducted within 2 days or less of the detachment (RD), according to a study in the Asia-Pacific Journal of Ophthalmology.

Researchers conducted a retrospective, noncomparative, interventional case series of 56 eyes with macula-on RD and 126 eyes with bullous macula-off RD.

When the duration of macula detachment was 2 days or less, approximately 90% of eyes achieved a postoperative 20/40 best-corrected visual acuity (BCVA). Between 2 and 10 days, the ratio of eyes achieving BCVA of 20/40 decreased (P = 0.008), plateauing around 40%. Mean BCVA showed a statistically significant decrease when the time from the RD to the vitrectomy/phacovitrectomy exceeded 10 days (P = 0.009).

"An increasing number of ophthalmologists are using vitrectomy as the first line of treatment for retinal detachment," the researchers said. "To achieve a good postoperative visual acuity, urgent surgery with a duration of macular detachment of 2 days or less is desired. Operative repair within this period, rather than outright emergency surgery, may be appropriate for most cases."

To view the abstract of this study, click here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.